{"product_id":"current-indications-for-the-implantable-cardioverter-defibrillator-isbn-9781405127790","title":"Current Indications for the Implantable Cardioverter Defibrillator","description":"In this book, well-known physicians, Bocker, Eckardt and Breithardt have put together a succinct and focused book that compliments the CATA Series well. Implantation of defibrillators has evolved dramatically since its introduction by Mirowski in 1980. Technological improvements in devices and leads included a gradual reduction in the size of the device, the introduction of the endocardial approach in 1988, the biphasic waveform and antitachycardia pacing in 1991, pectoral implantation in 1995, inclusion of DDD pacing in 1996 and the delivery of atrial therapies in 1998. \u003cbr\u003e \u003cp\u003eSince the first implantation, a huge body of information on the impact of implantable cardioverter defibrillators (ICD) on prognosis has become available, first as observational studies and later as prospective randomized trials. At the present time, there is a large evidence base from the several ICD trials, although it was not always certain that such a large body of ICD evidence would accumulate.\u003c\/p\u003e  Introduction. 4. \u003cp\u003eEvolution of guidelines for defibrillator therapy. 5.\u003c\/p\u003e \u003cp\u003eFormat of guidelines. 6.\u003c\/p\u003e \u003cp\u003eBackground of ICD therapy. 7.\u003c\/p\u003e \u003cp\u003eAims of ICD therapy. 7.\u003c\/p\u003e \u003cp\u003eClinical efficacy of ICD therapy. 8.\u003c\/p\u003e \u003cp\u003eAlternatives to ICD therapy. 8.\u003c\/p\u003e \u003cp\u003eComparison of drugs and devices. 10.\u003c\/p\u003e \u003cp\u003eCurrent indications for ICD therapy. 11.\u003c\/p\u003e \u003cp\u003eContraindications to ICD therapy. 11.\u003c\/p\u003e \u003cp\u003eICD therapy in specific disease states. 12.\u003c\/p\u003e \u003cp\u003eCAD. 12.\u003c\/p\u003e \u003cp\u003eRisk stratification. 13.\u003c\/p\u003e \u003cp\u003eSecondary prevention of cardiac arrest or sustained ventricular tachycardias in patients with coronary artery disease. 17.\u003c\/p\u003e \u003cp\u003ePrimary prevention of sudden cardiac death after myocardial infarction. 23.\u003c\/p\u003e \u003cp\u003eDCM... 26.\u003c\/p\u003e \u003cp\u003eSecondary prevention of cardiac arrest or sustained ventricular tachycardias in nonischemic dilated cardiomyopathy. 26.\u003c\/p\u003e \u003cp\u003ePrimary prevention of sudden cardiac death. 27.\u003c\/p\u003e \u003cp\u003eBrugada syndrome. 33.\u003c\/p\u003e \u003cp\u003eSecondary prevention of cardiac arrest in patients with Brugada syndrome. 34.\u003c\/p\u003e \u003cp\u003ePrimary prevention of sudden death in patients with the Brugada ECG pattern. 35.\u003c\/p\u003e \u003cp\u003eHypertrophic cardiomyopathy. 37.\u003c\/p\u003e \u003cp\u003eSecondary prevention of cardiac arrest or sustained ventricular tachycardias. 38.\u003c\/p\u003e \u003cp\u003ePrimary prevention of sudden death in HCM... 39.\u003c\/p\u003e \u003cp\u003eLong QT syndrome. 43.\u003c\/p\u003e \u003cp\u003eResults of ICD therapy in patients with the long QT syndrome. 46.\u003c\/p\u003e \u003cp\u003eShort QT Syndrome. 47.\u003c\/p\u003e \u003cp\u003eArrhythmogenic Right Ventricular Cardiomyopathy (ARVC) 48.\u003c\/p\u003e \u003cp\u003eCatecholamine- or exercise induced polymorphic ventricular tachycardia. 51.\u003c\/p\u003e \u003cp\u003eOther patients believed at high risk. 52.\u003c\/p\u003e \u003cp\u003eDefibrillators as a bridge to heart transplantation. 52.\u003c\/p\u003e \u003cp\u003eCardiac Resynchronization Therapy (CRT) 53.\u003c\/p\u003e \u003cp\u003eLegal implications of defibrillator guidelines. 56.\u003c\/p\u003e \u003cp\u003eLiterature. 64\u003c\/p\u003e  Author: Dirk Böcker, MD, Lars Eckardt, MD, Günter Breithardt, MD, FESC, FACC - University Hospital, Department of Cardiology and Angiology, Münster, Germany\u003cbr\u003e \u003cp\u003eEditor: A. John Camm\u003c\/p\u003e  \u003cu\u003e\u003cb\u003eGeneral Information\u003c\/b\u003e\u003c\/u\u003e\u003cbr\u003e \u003cp\u003eThis book will be number 18 in the list of titles within the CATA Series (Edited by A John Camm).\u003cbr\u003e \u003c\/p\u003e \u003cp\u003eThe aim of the CATA Series, devoted to cardiac arrhythmology, is to update the physician and cardiologist and all of those responsible for caring for patients with cardiac arrythmias about the spectacular developments in diagnostic and interventional cardiac electrophysiology. The introduction of techniques of catheter ablation have catapulted cardiac electrophysiology into the medical headlines.\u003cbr\u003e \u003c\/p\u003e \u003cp\u003e\u003cu\u003e\u003cb\u003eBook Specific Information\u003c\/b\u003e\u003c\/u\u003e\u003cbr\u003e \u003c\/p\u003e \u003cp\u003eIn this book, well-known physicians, Bocker, Eckardt and Breithardt have put together a succinct and focused book that compliments the CATA Series well. Implantation of defibrillators has evolved dramatically since its introduction by Mirowski in 1980. Technological improvements in devices and leads included a gradual reduction in the size of the device, the introduction of the endocardial approach in 1988, the biphasic waveform and antitachycardia pacing in 1991, pectoral implantation in 1995, inclusion of DDD pacing in 1996 and the delivery of atrial therapies in 1998.\u003cbr\u003e \u003c\/p\u003e \u003cp\u003eSince the first implantation, a huge body of information on the impact of implantable cardioverter defibrillators (ICD) on prognosis has become available, first as observational studies and later as prospective randomized trials. At the present time, there is a large evidence base from the several ICD trials, although it was not always certain that such a large body of ICD evidence would accumulate.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989015871717,"sku":"NP9781405127790","price":56.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781405127790.jpg?v=1761782445","url":"https:\/\/k12savings.com\/products\/current-indications-for-the-implantable-cardioverter-defibrillator-isbn-9781405127790","provider":"K12savings","version":"1.0","type":"link"}